Sessions

STRUCTURING YOUR LOCATION & FACILITY DESIGN TO ENSURE COMMERCIAL SUCCESS
THE ROLE OF NEW & ENABLING TECHNOLOGIES TO DRIVE EUROPEAN CGT COMMERCIALISATION SUCCESS
MARKET ACCESS & REIMBURSEMENT: REAL WORLD EVIDENCE & VALUE DEFINITION
INVESTING IN INVESTMENT: THE LONG TERM STRATEGY FOR CGT GROWTH IN EUROPE

STRUCTURING YOUR LOCATION & FACILITY DESIGN TO ENSURE COMMERCIAL SUCCESS

01 Sep 2022
13:30

13:30 – CHAIR INTRODUCTION

Chair: David Sourdive, Co-Founder & EVP CMC Manufacturing, Cellectis 

 

13:35 – CASE STUDY:

Speakers: David Sourdive, Co-Founder & EVP Strategic Initiatives, Cellectis 

 

13:55 – CASE STUDY: OPTIMISING FACILITY & LOCATION FOR CANCER CARE

Speaker: Troels Jordansen, CEO, Glycostem Therapeutics

 

14:15 – CASE STUDY: PATIENT, PLACE, PRICE; HOW ACADEMIC CDMO’S CAN BE COMMERCIALLY COMPETITIVE 

Speaker: Stuart Curbishley, Head of Business and Project Development – Advanced Therapies, University of Birmingham

 

14:35 – Q&A SESSION WITH SPEAKERS

Speakers: 

Troels Jordansen, CEO, Glycostem Therapeutics

Stuart Curbishley, Head of Business and Project Development – Advanced Therapies, University of Birmingham

David Sourdive, Co-Founder & EVP CMC Manufacturing, Cellectis

 

Speakers

David Sourdive
Co-Founder & EVP Strategic Initiatives
Cellectis
Stuart Curbishley
Head of Business and Project Development - Advanced Therapies
University of Birmingham